Skip to main content

Advertisement

SpringerLink
Log in

The dark side of glucose

  • News & Views
  • Published:

From Nature Medicine

View current issue Submit your manuscript

Non-enzymatic glycation, cellular receptors and oxidant stress together have implications for the pathogenesis of cellular dysfunction in diabetes and beyond (pages 1057–1061).

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Li, Y-M., Tan, A.X. & Vlassara, H. Antibacterial activity of lysozyme and lactoferrin is inhibited by binding of AGE-modifled proteins to a conserved motif. Nature Med. 1, 1057–1061 (1995).

    Article  CAS  Google Scholar 

  2. Ruderman, N., Wiliamson, J. & Brownlee, M. Glucose and diabetic vascular disease. FASEB J. 6, 2905–2914 (1992).

    Article  CAS  Google Scholar 

  3. Harrington, C. & Colaco, C.A.L.S. Alzheimer's disease: A glycation connection. Nature 370, 247–248 (1994).

    Article  CAS  Google Scholar 

  4. Miyata, T. et al. β2-Microglobulin modified with AGEs is a major component of hemodialysis-associated amyloidosis. J. clin. Invest. 92, 1243–1252 (1993).

    Article  CAS  Google Scholar 

  5. Yan, S-D. et al. Non-enzymatically glycated tau in Alzheimer's disease induces neuronal oxidant stress resulting in cytokine gene expression and release of amyloid β-peptide. Nature Med. 1, 693–699 (1995).

    Article  CAS  Google Scholar 

  6. Vitek, M. et al. AGEs contribute to amyloidosis in Alzheimer's disease. Proc. natn. Acad. Sci. U.S.A. 91, 4766–4770 (1994).

    Article  CAS  Google Scholar 

  7. Smith, M. et al. Advanced maillard reaction end-products are associated with Alzheimer disease pathology. Proc. natn. Acad. Sci. U.S.A. 91, 5710–5714 (1994).

    Article  CAS  Google Scholar 

  8. Palinski, W. et al. Immunological presence of AGEs in atherosclerotic lesions of euglycemic rabbits. Arterioscl. Thromb. Vase. Biol. 15, 571–582 (1995).

    Article  CAS  Google Scholar 

  9. Kirstein, M. et al. AGE induces transendothelial human monocyte chemotaxis and secretion of platelet-derived growth factor: Role in vascular disease of diabetes and aging. Proc. natn. Acad. Sci. U.S.A. 87, 9010–9014 (1990).

    Article  CAS  Google Scholar 

  10. Schmidt, A-M. et al. Regulation of human mononuclear phagocyte migration by cell surface binding proteins for AGEs. J. clin. Invest. 91, 2155–2168 (1993).

    Article  CAS  Google Scholar 

  11. Vlassara, H., Bucala, R. & Striker, L. Pathogenic effects of AGEs: Biochemical, biologic, and clinical implications for diabetes and aging. Lab. Invest. 70, 138–151 (1994).

    CAS  Google Scholar 

  12. Schmidt, A-M. et al. Cellular receptors for AGEs: Implications for induction of oxidant stress and cellular dysfunction in the pathogenesis of vascular lesions. Arteroscler. Thromb. 14, 1521–1528 (1994)

    Article  CAS  Google Scholar 

  13. Khoury, J. et al. Macrophages adhere to glucose-modified basement membrane via their scavenger receptors. J. biol. Chem. 269, 10197–10200 (1994).

    PubMed  Google Scholar 

  14. Schmidt, A-M., Hori, O., Chen, J., Brett, J. & Stern, D. AGE interaction with their endothelial receptor induces expression of VCAM-1: A potential mechanism for the accelerated vasculopa-thy of diabetes. J. Clin Invest. 96, 1375–1403 (1995).

    Article  Google Scholar 

  15. Li, H., Cybulsky, M., Gimbrone, M. & Libby, P. An atherogenic diet rapidly induces VCAM-1, a cytokine regulatable mononuclear leukocyte adhesion molecule, in rabbit aortic endothelium. Arteroscler. Thromb. 13, 197–204 (1993).

    Article  Google Scholar 

  16. Hori, O. et al. RAGE is a cellular binding site for amphoterin: Mediation of neurite outgrowth and co-expression of RAGE and amphoterin in the developing nervous system. J. biol. Chem. (in the press).

  17. Schmidt, A-M. et al. The endothelial binding site for AGEs consists of a complex: An integral membrane protein and a lactoferrin-like polypeptide. J. biol. Chem. 269, 9882–9888 (1994).

    CAS  PubMed  Google Scholar 

  18. Marhoffer, W., Stein, M., Maeser, E. & Federlin, K. Impairment of polymorphonuclear leukocyte function and metabolic control for diabetes. Diabetes Care 15, 256–260 (1992).

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Departments of Surgery, Pathology Physiology and Medicine Columbia University College of Physicians and Surgeons, New York, New York, 10032, USA

    Ann Marie Schmidt, Shi Du Yan & David M. Stern

Authors
  1. Ann Marie Schmidt
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Shi Du Yan
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. David M. Stern
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Schmidt, A., Yan, S. & Stern, D. The dark side of glucose. Nat Med 1, 1002–1004 (1995). https://doi.org/10.1038/nm1095-1002

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1038/nm1095-1002

  • Springer Nature America, Inc.

This article is cited by

Search

Navigation